1[1]Parik - Patel A, Gold EB, Utts J, et al. Functional status of patients with primary buliary cirrhosis[J ]. Am J Gastroenterol 2002,97(11): 2871. 被引量：1
2[2]Filipovic B, Opric M, Milicic A, et al. Primary biliary ctrrhosis[ J ]. Srp Arh Celok Lek, 2002, 139(5 - 6): 213. 被引量：1
3[3]Miyakawa H,Tanaka A,Kikuchi K,et al. Detection of antimitochondrial autoantibodies in immunofluorescent AMA- negative patients with primary biliary cirrhosis using recombinant autoantigenes[J ]. Hepatology, 2001,34:243. 被引量：1
4[4]Mee Lee Y, Kaplan MM. Efficacy of colchicines in patiets with primary biliary cirrhosis poorly responsive to ursosiol and methotrexate[J ]. Am J Gastroenterol 2003, 98(1) :205. 被引量：1
5[5]Jorgensen R, Angulo P, Dickson ER, et al. Results of longterm ursodiol treatment for patients with primary biliary cirrhosis[J ]. Am J Gastroenterol, 2002, 97(10): 2647. 被引量：1
6[6]Bach N, Bodian C, Bodenheimer H, et al. Methotrexate therapy for primary biliary cirrhosis[J ]. Am J Gastroenterol 2003, 98(1): 187. 被引量：1
10Chan CW, Gunsar F, Feudjo M, et al. Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years. Aliment Pharmacol Ther, 2005, 21. 217-226. 被引量：1
